Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address.
We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates.
Visit website: https://www.stealthbt.com/
People at Stealth BioTherapeutics
Co-Founder and Director at Improving Global Health, Inc. and Scientific Founder at Stealth BioTherapeutics.
CEO at Stealth BioTherapeutics.
Stealth BioTherapeutics News
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...